| CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL (NCT07294677) | University of Chicago | 2026-03-17 |
| Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor (NCT07484152) | University of Sao Paulo General Hospital | 2026-03-17 |
| Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment (NCT07498478) | TransThera Sciences (Nanjing), Inc. | 2026-03-17 |
| Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma (NCT07316010) | M.D. Anderson Cancer Center | 2026-03-17 |
| Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer (NCT07276880) | UNC Lineberger Comprehensive Cancer Center | 2026-03-17 |
| Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) (NCT07387471) | AbbVie | 2026-03-17 |
| Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms (NCT07492160) | Maimonides Medical Center | 2026-03-16 |
| Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD). (NCT07476872) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-16 |
| A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma (NCT07010497) | Asan Medical Center | 2026-03-16 |
| Modafinil to Improve Fatiguability (NCT05333250) | Ottawa Hospital Research Institute | 2026-03-16 |
| Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia (NCT07467993) | Novartis Pharmaceuticals | 2026-03-16 |
| Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) (NCT07501026) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-16 |
| cfMSC Therapy for Diabetes (NCT07495956) | Shenzhen Geno-Immune Medical Institute | 2026-03-16 |
| Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis (NCT07285070) | Novaliq GmbH | 2026-03-16 |
| A Study to Evaluate Crovalimab in People With Antiphospholipid Syndrome (APS) (NCT07172022) | Hoffmann-La Roche | 2026-03-16 |
| A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas (NCT07003542) | Case Comprehensive Cancer Center | 2026-03-16 |
| Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US (NCT07431086) | Regeneron Pharmaceuticals | 2026-03-16 |
| Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients (NCT07282483) | West China Hospital | 2026-03-16 |
| Gecacitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis (NCT07471503) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-16 |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) (NCT07291076) | Bristol-Myers Squibb | 2026-03-16 |
| Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer (NCT07475403) | Tianjin Medical University Second Hospital | 2026-03-16 |
| Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma (NCT06654050) | National Cancer Institute (NCI) | 2026-03-16 |
| Pulmonary Rehabilitation in Advanced Lung Cancer Survivors (NCT07104630) | Case Comprehensive Cancer Center | 2026-03-16 |
| Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia (NCT07504536) | Shanghai 7th People's Hospital | 2026-03-15 |
| Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial (NCT07474324) | The First Affiliated Hospital with Nanjing Medical University | 2026-03-15 |
| Tunlametinib Combination Therapy in KRAS-Mutated Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT07463677) | Sun Yat-sen University | 2026-03-15 |
| Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome (NCT07481422) | University of Rijeka | 2026-03-15 |
| Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial (NCT07514429) | Ju Hyun Shim | 2026-03-15 |
| CE-STAND: Cervical Epidural STimulation After Neurologic Damage (NCT06410001) | University of Minnesota | 2026-03-15 |
| Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis (NCT07454772) | All India Institute of Medical Sciences, Bhubaneswar | 2026-03-15 |
| Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer (NCT07448142) | Sun Yat-sen University | 2026-03-15 |
| VENTURI (VENTilation Using Respiratory Imaging) (NCT07282886) | University of Alabama at Birmingham | 2026-03-15 |
| Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia (NCT07486726) | Shanghai Jiao Tong University School of Medicine | 2026-03-15 |
| Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients (NCT07514455) | Ju Hyun Shim | 2026-03-15 |
| Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery (NCT07465185) | Benha University | 2026-03-15 |
| A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation (NCT07441512) | Hu Hai | 2026-03-15 |
| Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study) (NCT07472478) | Guangdong Provincial People's Hospital | 2026-03-15 |
| SHR-1701 in Combination With Irinotecan Liposome (II) for Second-line Treatment of ESCC After Immunotherapy (NCT07524374) | Zhigang Li | 2026-03-15 |
| Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma (NCT07476066) | Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd | 2026-03-15 |
| Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases (NCT07466927) | Fudan University | 2026-03-15 |
| Efficacy and Safety of Olverembatinib Plus Inotuzumab Ozogamicin as First-Line Consolidation Therapy Followed by HSCT in Ph+ ALL (NCT07443488) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-14 |
| The Efficacy and Safety of Luspatercept in Improving Early Anemia After HSCT (NCT07450313) | Institute of Hematology & Blood Diseases Hospital, China | 2026-03-14 |
| Probenecid Administration for Alcohol Craving and Consumption (NCT07118618) | Brown University | 2026-03-14 |
| Simvastatin Efficacy in ARID1A Mutated Advanced gastroESophageal Carcinoma Treated With Immunotherapy (NCT07213557) | National Cancer Institute, Naples | 2026-03-13 |
| Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma (NCT07324629) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-03-13 |
| A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer (NCT07483307) | Memorial Sloan Kettering Cancer Center | 2026-03-13 |
| A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation (NCT07412470) | Sanofi | 2026-03-13 |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) (NCT07221149) | Bristol-Myers Squibb | 2026-03-13 |
| A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression (NCT07396272) | Daniel Lindqvist | 2026-03-13 |
| Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC (NCT06863311) | Karie Runcie | 2026-03-13 |
| Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01 (NCT07290894) | National Cancer Institute, Naples | 2026-03-12 |
| A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis (NCT07364448) | Beijing Continent Pharmaceutical Co, Ltd. | 2026-03-12 |
| A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder (NCT07475806) | Astellas Pharma Global Development, Inc. | 2026-03-12 |
| Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine (NCT07418372) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2026-03-12 |
| Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC (NCT07457528) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-12 |
| Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo (NCT07152626) | Centre Hospitalier Universitaire de Nice | 2026-03-12 |
| Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer (NCT07407647) | Ohio State University Comprehensive Cancer Center | 2026-03-12 |
| Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma (NCT07362979) | Sun Yat-sen University | 2026-03-12 |
| The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. (NCT07445308) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2026-03-12 |
| Total Intravenous Anesthesia vs Spinal Anesthesia in Patients Undergoing Unilateral Primary Total Knee Arthroplasty (NCT07672301) | University of Chicago | 2026-03-11 |
| A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC (NCT07491497) | TRIANA Biomedicines, Inc. | 2026-03-11 |
| Glucose Tolerance Study (NCT07412730) | RDC Clinical Pty Ltd | 2026-03-11 |
| A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT07287150) | Hoffmann-La Roche | 2026-03-11 |
| A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma (NCT07477457) | Memorial Sloan Kettering Cancer Center | 2026-03-11 |
| Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer (NCT07421700) | Pfizer | 2026-03-11 |
| A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea (NCT07235917) | Regeneron Pharmaceuticals | 2026-03-11 |
| The Efficacy and Safety of Pucotenlimab (PD-1) Combined With Becotatugvedotin (EGFR-ADC) in Advanced Cholangiocarcinoma (NCT07514533) | Sir Run Run Shaw Hospital | 2026-03-11 |
| Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda (NCT07276360) | Uganda Cancer Institute | 2026-03-11 |
| Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations (NCT07336732) | Avistone Biotechnology Co., Ltd. | 2026-03-11 |
| A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency (NCT07347249) | Hemab ApS | 2026-03-11 |
| Ascorbate in Myelodysplastic Syndrome (NCT07283900) | Prajwal Dhakal | 2026-03-11 |
| Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer (NCT07471776) | Fudan University | 2026-03-11 |
| Stem Cell Therapy for Early Alzheimer's Disease (NCT06775964) | Paul E Schulz | 2026-03-11 |
| A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease (NCT07349524) | Reistone Biopharma Company Limited | 2026-03-10 |
| cfMSC Stem Cell Therapy Targeting COPD (NCT07477600) | Shenzhen Geno-Immune Medical Institute | 2026-03-10 |
| Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy (NCT07574385) | Rebel Medicine Inc | 2026-03-10 |
| Phase II Trial of RC1416 Injection in Asthma (NCT07403487) | Nanjing RegeneCore Biotech Co., Ltd. | 2026-03-10 |
| Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity (NCT07564479) | Minia University | 2026-03-10 |
| AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF (NCT07194382) | Avalyn Pharma Inc. | 2026-03-10 |
| A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP) (NCT07408232) | Octant, Inc. | 2026-03-10 |
| ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) (NCT06951646) | Second Xiangya Hospital of Central South University | 2026-03-10 |
| Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma. (NCT07469241) | Fudan University | 2026-03-10 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS) (NCT07282574) | Hoffmann-La Roche | 2026-03-10 |
| A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (NCT07061574) | City of Hope Medical Center | 2026-03-10 |
| A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT07441642) | Novartis Pharmaceuticals | 2026-03-09 |
| Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC (NCT07397611) | Dana-Farber Cancer Institute | 2026-03-09 |
| A Study of SHR-2173 in Participants With Primary IgA Nephropathy (NCT07354932) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-03-09 |
| Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response (NCT07142551) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-03-09 |
| Alendronate for Osteonecrosis in Adults With Sickle Cell Disease (NCT06016634) | University of California, Davis | 2026-03-09 |
| Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) (NCT07389278) | Sabine Mueller, MD, PhD | 2026-03-09 |
| PDT For Induction Therapy For Head And Neck Cancer (NCT07214987) | Massachusetts General Hospital | 2026-03-09 |
| A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo (NCT07431177) | Novartis Pharmaceuticals | 2026-03-09 |
| A Study of Liposomal Irinotecan Plus 5-FU/LV HAIC With Lenvatinib and a PD-1 Inhibitor in Advanced ICC (NCT07432568) | Tianjin Medical University Cancer Institute and Hospital | 2026-03-09 |
| Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention (NCT06926595) | Milton S. Hershey Medical Center | 2026-03-09 |
| A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure (NCT07562087) | Tarsus Pharmaceuticals, Inc. | 2026-03-09 |
| A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (NCT07306182) | Beijing Sungen Biomedical Technology Co., Ltd | 2026-03-09 |
| Chaigui Longmu Ejiao Paste for Ischemic Heart Disease (NCT07478328) | Longhua Hospital | 2026-03-08 |
| Ferumoxytol-enhanced Magnetic Resonance Venography in Patients With Venous Diseases (NCT07452250) | Min Zhou | 2026-03-08 |
| Evaluation of the Outcome of Fecal Microbiota Transplantation (NCT07454408) | Air Force Military Medical University, China | 2026-03-07 |
| CAR-NK Therapy for Cardiac Amyloidosis (NCT07504289) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-03-07 |